Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xaria X Li

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
STAR Protocols|November 30, 2023
Protocol for cell-based screening assay to measure ERK1/2 phosphorylation as a readout for complement receptor activationXaria X Li, Trent M Woodruff
Pharmacological Reviews|July 19, 2025
The complement system: Biology, pathology, and therapeutic interventionsXaria X Li, Trent M Woodruff
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2020
C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human MacrophagesXaria X Li, Richard J Clark, Trent M Woodruff
International Immunopharmacology|August 28, 2021
Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonistsXaria X Li, Richard J Clark, Trent M Woodruff
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2019
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive ImmunityXaria X Li, John D Lee, Claudia Kemper, et al.
Trends in Biochemical Sciences|May 14, 2020
Emerging Insights into the Structure and Function of Complement C5a ReceptorsShubhi Pandey, Jagannath Maharana, Xaria X Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
Cell-intrinsic C5a synergizes with Dectin-1 in macrophages to mediate fungal killingXaria X Li, Jenny N Fung, Richard J Clark, et al.
Frontiers in Pharmacology|February 8, 2021
The "C3aR Antagonist" SB290157 is a Partial C5aR2 AgonistXaria X Li, Vinod Kumar, Richard J Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2021
Unexpected Off-Target Activities for Recombinant C5a in Human MacrophagesXaria X Li, Declan M Gorman, John D Lee, et al.
Molecular Immunology|June 4, 2017
New concepts on the therapeutic control of complement anaphylatoxin receptorsOwen A Hawksworth, Xaria X Li, Liam G Coulthard, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
STAR Protocols|November 30, 2023
Protocol for cell-based screening assay to measure ERK1/2 phosphorylation as a readout for complement receptor activationXaria X Li, Trent M Woodruff
Pharmacological Reviews|July 19, 2025
The complement system: Biology, pathology, and therapeutic interventionsXaria X Li, Trent M Woodruff
Journal of Immunology (Baltimore, Md. : 1950)|July 3, 2020
C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human MacrophagesXaria X Li, Richard J Clark, Trent M Woodruff
International Immunopharmacology|August 28, 2021
Anaphylatoxin receptor promiscuity for commonly used complement C5a peptide agonistsXaria X Li, Richard J Clark, Trent M Woodruff
Journal of Immunology (Baltimore, Md. : 1950)|June 5, 2019
The Complement Receptor C5aR2: A Powerful Modulator of Innate and Adaptive ImmunityXaria X Li, John D Lee, Claudia Kemper, et al.
Trends in Biochemical Sciences|May 14, 2020
Emerging Insights into the Structure and Function of Complement C5a ReceptorsShubhi Pandey, Jagannath Maharana, Xaria X Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2024
Cell-intrinsic C5a synergizes with Dectin-1 in macrophages to mediate fungal killingXaria X Li, Jenny N Fung, Richard J Clark, et al.
Frontiers in Pharmacology|February 8, 2021
The "C3aR Antagonist" SB290157 is a Partial C5aR2 AgonistXaria X Li, Vinod Kumar, Richard J Clark, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2021
Unexpected Off-Target Activities for Recombinant C5a in Human MacrophagesXaria X Li, Declan M Gorman, John D Lee, et al.
Molecular Immunology|June 4, 2017
New concepts on the therapeutic control of complement anaphylatoxin receptorsOwen A Hawksworth, Xaria X Li, Liam G Coulthard, et al.
Pageof 3